Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Celaid Therapeutics ¥400M Series B second closeDioseve $7M Series A+Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Celaid Therapeutics ¥400M Series B second closeDioseve $7M Series A+New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Spectronix ¥518M Series F extensionEight Knot, Inc. ¥450M Series A first closeNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
JAOPS ¥260M SeedARK Co., Ltd. ~¥1.3B Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
WAYFARER, Inc. Undisclosed Series A first closeKnowledge Work ¥3.5B Series C first closeNew companies 2 · Follow-on 0
Stages: Seed 2
Smolt Co., Ltd. ~¥200M Pre-Series A extensionGEMBA Co., Ltd. ¥45M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
BridgeSmile Co., Ltd. ¥819M Series AKG Motors Co., Ltd. ¥470M Equity financingNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
BridgeSmile Co., Ltd. ¥819M Series ASmolt Co., Ltd. ~¥200M Pre-Series A extensionNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
DeltaForesight, Inc. Undisclosed J-KISS financingJosan-she's, Inc. ¥400M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Facilo, Inc. ¥6.4B Series BAOI Biosciences, Inc. Undisclosed Equity issuance and secondary transferNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
QueryLift, Inc. ¥100M SeedOcean, Inc. Undisclosed Series A first closeNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
CADDi ¥17.7B Series Dnocall, Inc. ~¥800M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Ocean, Inc. Undisclosed Series A first close10pct., Inc. ~¥400M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Ocean, Inc. Undisclosed Series A first closeYoom, Inc. ¥700M First external financingNew companies 2 · Follow-on 0
Stages: Series A 2
Josan-she's, Inc. ¥400M Series ASiccaNova Therapeutics ¥1.3B Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Kiviaq, Inc. ¥150M Pre-Series ALOMBY, Inc. ¥387M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
VALT JAPAN Inc. Undisclosed Third-party allotmentStarlight Engine $37.4M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Tellus Global Inc. >¥900M MBO financingDioseve $7M Series A+New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Tellus Global Inc. >¥900M MBO financingBeff Inc. ¥450M Series A first closeNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Rege Nephro Co $10.6M Series CStarlight Engine $37.4M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.